Table 7 Estimates of prevalence (P), intracluster correlation coefficients (ICC), their respective 95% CI, design effect (Deff), and mean cluster size (n a ) for categorical newborn outcome variables
Variable | P(%) | ICC | 95% CI for ICC | Deff | na |
|---|---|---|---|---|---|
Diagnosis of gestational age (US) | 45.4 | 0.264 | 0.128-0.399 | 84.8 | 265 |
Stillborn | 3.1 | 0.026 | 0.006-0.046 | 7.5 | 265 |
Intubation at delivery | 13.4 | 0.013 | 0.002-0.024 | 4.1 | 248 |
Use of surfactant | 12.6 | 0.015 | 0.002-0.027 | 4.4 | 245 |
Fetal malformation | 9.5 | 0.078 | 0.026-0.130 | 19.6 | 246 |
Ventilatory support | 42.6 | 0.041 | 0.011-0.070 | 15.1 | 249 |
Neonatal morbidity | 60.3 | 0.126 | 0.047-0.205 | 33.4 | 248 |
● Sepsis | 27.7 | 0.051 | 0.011-0.091 | 8.3 | 144 |
● Respiratory distress | 73.4 | 0.061 | 0.014-0.107 | 9.9 | 148 |
● Pneumothorax | 3.6 | 0.041 | 0.007-0.075 | 8.2 | 141 |
● Cerebral hemorrhage (1–4) | 8.7 | 0.052 | 0.007-0.097 | 5.8 | 114 |
● Lung hemorrhage | 3.7 | 0.028 | 0.004-0.053 | 5.7 | 143 |
● Hematologic dysfunction | 51.0 | 0.267 | 0.116-0.417 | 71.7 | 146 |
● Endocrine dysfunction | 22.0 | 0.119 | 0.036-0.201 | 30.3 | 145 |
● Renal dysfunction | 6.4 | 0.013 | <0.001-0.027 | 3.5 | 145 |
● Immune dysfunction | 6.5 | 0.092 | 0.025-0.158 | 22.1 | 145 |
● Musculoskeletal morbidity | 8.6 | 0.190 | 0.071-0.310 | 38.4 | 146 |
● Gastrointestinal dysfunction | 43.2 | 0.340 | 0.168-0.512 | 70.6 | 146 |
● Hypovolemia | 10.4 | 0.026 | 0.003-0.049 | 6.0 | 146 |
● Necrotizing enterocolitis | 2.4 | 0.020 | 0.001-0.038 | 3.2 | 145 |
● Convulsion/anticonvulsants | 4.8 | 0.039 | 0.007-0.071 | 6.7 | 146 |
● Vasoactive amines | 12.2 | 0.019 | 0.001-0.037 | 3.5 | 146 |
● Pneumonia | 5.6 | 0.118 | 0.036-0.200 | 15.6 | 145 |
● Oxygen therapy with 28 days | 8.0 | 0.021 | 0.002-0.041 | 3.8 | 145 |
● Oxygen therapy with 56 days | 2.9 | 0.012 | <0.001-0.025 | 2.8 | 143 |
● Degree of retinopathy (1–3) | 4.8 | 0.028 | <0.001-0.056 | 4.2 | 99 |
Condition at discharge (live) | 91.8 | 0.014 | 0.002-0.026 | 4.1 | 252 |